Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
about
Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasionHepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferonHBV pathogenesis in animal models: recent advances on the role of plateletsInnate immune targets of hepatitis B virus infectionCrosstalk between innate and adaptive immunity in hepatitis B virus infectionInnate Immunity and Immune Evasion by Enterovirus 71Anti-HBV Drugs: Progress, Unmet Needs, and New HopeRecognition of human oncogenic viruses by host pattern-recognition receptorsToll-like receptors in antiviral innate immunityPotential mechanisms of hepatitis B virus induced liver injuryRole of innate immunity in the development of hepatocellular carcinomaStealth and cunning: hepatitis B and hepatitis C viruses.Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus InfectionEfficacy of cationic lipid–DNA complexes (CLDC) on hepatitis B virus in transgenic miceToll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesToll-like receptors in pathophysiology of liver diseasesCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infectionImmune therapy for hepatitis BNF-κB, JNK, and TLR Signaling Pathways in HepatocarcinogenesisThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaCharacterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging AlphavirusesInhibition of hepatitis B virus gene expression & replication by crude destruxins from Metarhizium anisopliae var. dcjhyiumPromising therapies for treatment of nonalcoholic steatohepatitis.Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.Tickling the TLR7 to cure viral hepatitis.Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.Novel approaches towards conquering hepatitis B virus infection.Emerging antivirals for the treatment of hepatitis B.Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma.Pathogenesis of hepatitis B virus infectionKupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease.Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells.Toll-like receptors in the pathogenesis of alcoholic liver disease.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysHepatocyte death: a clear and present danger.Toll-like receptor 3 in liver diseases.Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.Strategies to eliminate HBV infection.Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.
P2860
Q24293039-05005C3A-A0D0-4262-9C3F-0AF833E1929BQ24306639-FA562B4F-AC5C-4C79-B5D1-3B32904093EEQ24672103-21498CAD-8593-47B8-ACFA-E5C59E83A5E1Q26743647-14A31024-C3EC-429D-8567-BF6CCF7803D2Q26771142-42096FF7-8042-43F6-A7C1-B54B3DC290C6Q26773329-F5F2BFFB-2C29-4BFA-A3A4-9277569B08D6Q26782742-3D645593-A074-4444-B190-5FE1C0BBF042Q27010116-8204B94D-1D26-4767-926B-9F8413B16B45Q27011462-F9758753-1942-4F2F-B72A-705CABBA8082Q27014079-37222F25-BC81-4D66-8391-EBF490817FCEQ27024780-BAB9CDBA-A2FB-4A5D-890C-4D66EC8C90BEQ27470232-605FB9AB-254C-405F-A843-93CAA8A5768DQ27480922-C1AF4393-BBCA-4921-BADD-461F14D59BB5Q27486380-C7CC382F-A773-4EBC-8BD8-A36FA0335403Q27487393-7A4C8776-6579-46B3-9B3B-DC3D0361210CQ28070077-25035DC3-B533-4987-86A6-92D6D9BD8FC0Q28076279-46802EC4-00C5-4CCF-98D7-DBC050BCB921Q28078856-2FE8EB68-8939-4340-931D-559E54D50936Q28384956-84B0A491-FA1E-42B7-9181-BC5FA8D85DB6Q28392224-62E02FB3-280C-440C-9D96-84E2B00DB15EQ28551420-078F651C-1B2C-43FE-92C5-98DE5E63B0DFQ28660336-805AF522-D738-4170-8839-FBA4CEC95CF3Q30248578-7DFD990E-7C27-4EE8-AB1B-D3589CF3631CQ30432794-745950D5-FA86-4A9D-8D10-96FA04816784Q30854409-596C8392-E42B-47D8-9CCA-507A53266BEAQ33690260-85FE27D4-3509-4201-AB5F-1D153D080947Q33784869-A6FB4E34-53A2-4F80-9EDB-8B4723E05C17Q33787687-27B1F33F-84A7-402E-8EFB-58D029385F16Q33801328-DB470AE7-A36A-4DE1-917C-7602E05C1E6AQ33894934-BE70FA29-AD12-4C46-B940-C03CC079F47FQ33925491-C9280B63-6EA0-47DD-B6D8-085FE3481F67Q33926022-87302488-CB06-4F65-8575-2603278782C9Q33988856-AB0E2D6D-C444-4E1D-8A0D-B90597E8462BQ34106192-733EE127-EC20-4488-8FDE-0E20602A0600Q34137297-E81B74C9-9394-4176-9347-8D4F62BDCE1BQ34147508-16579277-6DFD-49FC-8994-BE931D271FBCQ34170010-D4AF6D2A-5147-4406-A8B4-BE46389F0A27Q34262302-BD9AC04C-F2FF-4BFF-AC6A-62AA9E48149FQ34308129-5C2F7043-01B7-491A-8B62-EDCE647BC90DQ34321742-67EED032-24FF-4169-AD4B-2318DED44BEA
P2860
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@ast
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@en
type
label
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@ast
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@en
prefLabel
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@ast
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
@en
P2860
P1433
P1476
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
@en
P2093
Michael D Robek
Yoshihiro Furuichi
P2860
P304
P356
10.1128/JVI.79.11.7269-7272.2005
P577
2005-06-01T00:00:00Z